CD3E (CD3 Epsilon Subunit Of T-Cell Receptor Complex) is a Protein Coding gene. Diseases associated with CD3E include Immunodeficiency 18 and T-B+ Severe Combined Immunodeficiency Due To Cd3delta/Cd3epsilon/Cd3zeta. Among its related pathways are Immune response NFAT in immune response and TCR Signaling (Qiagen). Gene Ontology (GO) annotations related to this gene include protein heterodimerizatio...
Stabilin-2 is a protein that in humans is encoded by the STAB2 gene.
The global STAB2 Antibody (Stabilin-2 Precursor) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to prov...
TSG-6 forms a stable complex with the serine protease inhibitor Inter-alpha -Inhibitor (I alpha I) and potentiates the anti-plasmin activity of I alpha I. Tumor Necrosis Factor-stimulated Gene Sequence 6.
The global TSG6 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regio...
Versican (VCAN), also known as CSPG2, is a large extracellular matrix proteoglycan that is present in a variety of human tissues. Versican is a large chondroitin sulfate proteoglycan with an apparent molecular mass of more than 1000 kDa. The Versican gene is mapped on 5q14.2-q14.3. The human versican gene contains 15 exons spanning more than 90 kb. The distribution of versican by using affinity-pu...
CHST15 (Carbohydrate Sulfotransferase 15) is a Protein Coding gene. Diseases associated with CHST15 include Spondyloepiphyseal Dysplasia With Congenital Joint Dislocations and Larsen Syndrome.
The global CHST15 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North...
EXT1 Antibody (A-7) is an IgG1 κ mouse monoclonal EXT1 antibody (also designated EXT1 antibody) that detects the EXT1 protein of mouse, rat and human origin by WB, IP, IF and ELISA.
The global EXT1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is ex...
EXTL1 (Exostosin Like Glycosyltransferase 1) is a Protein Coding gene. Diseases associated with EXTL1 include Hereditary Multiple Exostoses and Exostosis.
The global EXTL1 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
In terms of regions, North America is expected to remain the large...
EXTL2 (Exostosin Like Glycosyltransferase 2) is a Protein Coding gene. Diseases associated with EXTL2 include Hereditary Multiple Exostoses and Breast Pericanalicular Fibroadenoma. Among its related pathways are Unfolded Protein Response (UPR) and Cellular responses to stimuli.
The global EXTL2 Antibody market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witn...
EXTL3 (Exostosin Like Glycosyltransferase 3) is a Protein Coding gene. This gene encodes a single-pass membrane protein which functions as a glycosyltransferase. The encoded protein catalyzes the transfer of N-acetylglucosamine to glycosaminoglycan chains. This reaction is important in heparin and heparan sulfate synthesis.
The global EXTL3 Antibody market was valued at US$ million in 2023 and is...
FAM20B (FAM20B Glycosaminoglycan Xylosylkinase) is a Protein Coding gene. Diseases associated with FAM20B include Desbuquois Dysplasia and Gingival Fibromatosis. Gene Ontology (GO) annotations related to this gene include kinase activity and phosphotransferase activity, alcohol group as acceptor.
The global FAM20B Gene (XYLK Antibody) market was valued at US$ million in 2023 and is anticipated to...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals